SEARCH

SEARCH BY CITATION

References

  • 1
    Lok ASF, McMahon BJ. Chronic hepatitis B. HEPATOLOGY 2007; 45: 507539.
  • 2
    Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008; 359: 24422455.
  • 3
    Sheldon J, Camino N, Rodés B, Bartholomeusz A, Kuiper M, Tacke F, et al. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther 2005; 10: 727734.
  • 4
    Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, et al. Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis 2002; 40: 13311333.
  • 5
    Sasadeusz J, Audsley J, Mijch A, Baden R, Caro J, Hunter H, et al. The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients. AIDS 2008; 22: 947955.
  • 6
    Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al.; Centers for Disease Control and Prevention. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 57(RR-8): 120.